The North America self-monitoring blood glucose devices market size exceeded USD 7,133.6 million in 2020 and is anticipated to expand at a CAGR of 9.6% from 2021 to 2027. Continuous glucose monitors segment held more than 10% revenue share in 2020.

North America Self-Monitoring Blood Glucose Devices Market Forecasts 2027

North America Self-Monitoring Blood Glucose (SMBG) Devices Market Forecast 2027 By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Definition and forecast parameters

1.1.1&nbsp;&nbsp;&nbsp; Definitions

1.1.2&nbsp;&nbsp;&nbsp; Methodology and forecast parameters

1.2&nbsp;&nbsp;&nbsp; Data sources

1.3&nbsp;&nbsp;&nbsp; References &amp; sources

1.3.1&nbsp;&nbsp;&nbsp; Secondary

1.3.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Market Summary

2.1&nbsp;&nbsp;&nbsp; North America self-monitoring blood glucose (SMBG) devices industry summary, 2016 &ndash; 2027

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; Distribution channel trends

Chapter 3&nbsp;&nbsp;&nbsp;Market Analysis

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry outlook, 2016 &ndash; 2027 (USD Million)

3.3&nbsp;&nbsp;&nbsp; Major factor analysis

3.3.1&nbsp;&nbsp;&nbsp; Drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Individual and national expenditure over diabetes treatment

3.3.1.2&nbsp;&nbsp;&nbsp; Technological advancements in self-monitoring glucose devices

3.3.1.3&nbsp;&nbsp;&nbsp; Increasing adoption of sedentary lifestyle and rising obese population prone to suffer from diabetes

3.3.1.4&nbsp;&nbsp;&nbsp; Growing prevalence of diabetes

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; High cost associated with SMBG devices

3.4&nbsp;&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive review, 2020

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Product

4.1&nbsp;&nbsp;&nbsp; Market trends

4.2&nbsp;&nbsp;&nbsp; Self-monitoring blood glucose meters

4.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Continuous glucose monitors

4.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Testing strips

4.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Lancets

4.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Application

5.1&nbsp;&nbsp;&nbsp; Market trends

5.2&nbsp;&nbsp;&nbsp; Type 1 diabetes

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Type 2 diabetes

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Gestational diabetes

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Distribution Channel

6.1&nbsp;&nbsp;&nbsp; Market trends

6.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Retail pharmacies

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Online sales

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Diabetes Clinics &amp; Centers

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Country

7.1&nbsp;&nbsp;&nbsp; Market trends

7.2&nbsp;&nbsp;&nbsp; U.S.

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by product, 2016 &ndash; 2027 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2016 &ndash; 2027 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by distribution channel, 2016 &ndash; 2027 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Canada

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by product, 2016 &ndash; 2027 (USD Million)

7.3.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2016 &ndash; 2027 (USD Million)

7.3.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by distribution channel, 2016 &ndash; 2027 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.1.1&nbsp;&nbsp;&nbsp; Business overview

8.1.2&nbsp;&nbsp;&nbsp; Financial data

8.1.3&nbsp;&nbsp;&nbsp; Product landscape

8.1.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.1.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.2&nbsp;&nbsp;&nbsp; Arkray

8.2.1&nbsp;&nbsp;&nbsp; Business overview

8.2.2&nbsp;&nbsp;&nbsp; Financial data

8.2.3&nbsp;&nbsp;&nbsp; Product landscape

8.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.2.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.3&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

8.3.1&nbsp;&nbsp;&nbsp; Business overview

8.3.2&nbsp;&nbsp;&nbsp; Financial data

8.3.3&nbsp;&nbsp;&nbsp; Product landscape

8.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.3.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.4&nbsp;&nbsp;&nbsp; Bayer Healthcare

8.4.1&nbsp;&nbsp;&nbsp; Business overview

8.4.2&nbsp;&nbsp;&nbsp; Financial data

8.4.3&nbsp;&nbsp;&nbsp; Product landscape

8.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.4.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.5&nbsp;&nbsp;&nbsp; Bionime Corporation.

8.5.1&nbsp;&nbsp;&nbsp; Business overview

8.5.2&nbsp;&nbsp;&nbsp; Financial data

8.5.3&nbsp;&nbsp;&nbsp; Product landscape

8.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.5.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

8.6.1&nbsp;&nbsp;&nbsp; Business overview

8.6.2&nbsp;&nbsp;&nbsp; Financial data

8.6.3&nbsp;&nbsp;&nbsp; Product landscape

8.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.6.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.7&nbsp;&nbsp;&nbsp; Platinum Equity (LifeScan)

8.7.1&nbsp;&nbsp;&nbsp; Business overview

8.7.2&nbsp;&nbsp;&nbsp; Financial data

8.7.3&nbsp;&nbsp;&nbsp; Product landscape

8.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.7.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.8&nbsp;&nbsp;&nbsp; Agamatrix Inc

8.8.1&nbsp;&nbsp;&nbsp; Business overview

8.8.2&nbsp;&nbsp;&nbsp; Financial data

8.8.3&nbsp;&nbsp;&nbsp; Product landscape

8.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.8.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.9&nbsp;&nbsp;&nbsp; Dexcom

8.9.1&nbsp;&nbsp;&nbsp; Business overview

8.9.2&nbsp;&nbsp;&nbsp; Financial data

8.9.3&nbsp;&nbsp;&nbsp; Product landscape

8.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.9.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.10&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson

8.10.1&nbsp;&nbsp;&nbsp; Business overview

8.10.2&nbsp;&nbsp;&nbsp; Financial data

8.10.3&nbsp;&nbsp;&nbsp; Product landscape

8.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.10.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.11&nbsp;&nbsp;&nbsp; Medtronic

8.11.1&nbsp;&nbsp;&nbsp; Business overview

8.11.2&nbsp;&nbsp;&nbsp; Financial data

8.11.3&nbsp;&nbsp;&nbsp; Product landscape

8.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.11.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.12&nbsp;&nbsp;&nbsp; Nipro Diagnostics

8.12.1&nbsp;&nbsp;&nbsp; Business overview

8.12.2&nbsp;&nbsp;&nbsp; Financial data

8.12.3&nbsp;&nbsp;&nbsp; Product landscape

8.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.12.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.13&nbsp;&nbsp;&nbsp; Nova Biomedical

8.13.1&nbsp;&nbsp;&nbsp; Business overview

8.13.2&nbsp;&nbsp;&nbsp; Financial data

8.13.3&nbsp;&nbsp;&nbsp; Product landscape

8.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.13.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.14&nbsp;&nbsp;&nbsp; Trividia Health

8.14.1&nbsp;&nbsp;&nbsp; Business overview

8.14.2&nbsp;&nbsp;&nbsp; Financial data

8.14.3&nbsp;&nbsp;&nbsp; Product landscape

8.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.14.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.15&nbsp;&nbsp;&nbsp; Sinocare

8.15.1&nbsp;&nbsp;&nbsp; Business overview

8.15.2&nbsp;&nbsp;&nbsp; Financial data

8.15.3&nbsp;&nbsp;&nbsp; Product landscape

8.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.15.5&nbsp;&nbsp;&nbsp; SWOT analysis 
&nbsp;

Request sample

Contact us

Need Help ?

Get In Touch

Address

Contact

Phone :

Email:

Company

Information

Links